Quarterly Result30 May 2025, 06:58 pm
Biofil Chemicals & Pharmaceuticals Ltd. Reports FY2024-25 Financial Results with 55.78% YoY Profit Growth
AI Summary
Biofil Chemicals & Pharmaceuticals Ltd. has announced its audited financial results for the year ended 31st March 2025. The company's revenue from operations stands at INR 3,370.74 lakhs, marking a 24.87% YoY growth. The profit before tax is INR 24.87 lakhs, a 55.78% YoY increase. The company has two major segments: Pharma and Chemicals. The Pharma Division contributed INR 2,786.79 lakhs in revenue, while the Chemicals Division contributed INR 674.18 lakhs. The company's earnings per share (EPS) for the period is INR 2.80. The audited financial results have been reviewed and approved by the Audit Committee and the Board of Directors.
Key Highlights
- Revenue from operations stands at INR 3,370.74 lakhs, marking a 24.87% YoY growth.
- Profit before tax is INR 24.87 lakhs, a 55.78% YoY increase.
- Pharma Division contributed INR 2,786.79 lakhs in revenue, while the Chemicals Division contributed INR 674.18 lakhs.
- Earnings per share (EPS) for the period is INR 2.80.
- Audited financial results have been reviewed and approved by the Audit Committee and the Board of Directors.